Logo image of 1SHL.MI

SIEMENS HEALTHINEERS AG (1SHL.MI) Stock Fundamental Analysis

BIT:1SHL - Euronext Milan - DE000SHL1006 - Common Stock - Currency: EUR

54.08  +5.29 (+10.84%)

Fundamental Rating

4

Taking everything into account, 1SHL scores 4 out of 10 in our fundamental rating. 1SHL was compared to 55 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of 1SHL while its profitability can be described as average. 1SHL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year 1SHL was profitable.
1SHL had a positive operating cash flow in the past year.
1SHL had positive earnings in each of the past 5 years.
In the past 5 years 1SHL always reported a positive cash flow from operatings.
1SHL.MI Yearly Net Income VS EBIT VS OCF VS FCF1SHL.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

1.2 Ratios

1SHL's Return On Assets of 4.00% is fine compared to the rest of the industry. 1SHL outperforms 65.45% of its industry peers.
Looking at the Return On Equity, with a value of 10.22%, 1SHL is in the better half of the industry, outperforming 70.91% of the companies in the same industry.
With a decent Return On Invested Capital value of 5.85%, 1SHL is doing good in the industry, outperforming 63.64% of the companies in the same industry.
1SHL had an Average Return On Invested Capital over the past 3 years of 5.68%. This is below the industry average of 8.28%.
The last Return On Invested Capital (5.85%) for 1SHL is above the 3 year average (5.68%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4%
ROE 10.22%
ROIC 5.85%
ROA(3y)3.83%
ROA(5y)4.89%
ROE(3y)9.79%
ROE(5y)11.34%
ROIC(3y)5.68%
ROIC(5y)7.29%
1SHL.MI Yearly ROA, ROE, ROIC1SHL.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40 50

1.3 Margins

The Profit Margin of 1SHL (8.43%) is better than 63.64% of its industry peers.
1SHL's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 12.32%, 1SHL is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
1SHL's Operating Margin has declined in the last couple of years.
1SHL has a worse Gross Margin (37.82%) than 74.55% of its industry peers.
1SHL's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 12.32%
PM (TTM) 8.43%
GM 37.82%
OM growth 3Y-9.96%
OM growth 5Y-7.42%
PM growth 3Y-10.65%
PM growth 5Y-5.87%
GM growth 3Y-2.69%
GM growth 5Y-2.67%
1SHL.MI Yearly Profit, Operating, Gross Margins1SHL.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1SHL is still creating some value.
Compared to 1 year ago, 1SHL has less shares outstanding
The number of shares outstanding for 1SHL has been increased compared to 5 years ago.
Compared to 1 year ago, 1SHL has a worse debt to assets ratio.
1SHL.MI Yearly Shares Outstanding1SHL.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B
1SHL.MI Yearly Total Debt VS Total Assets1SHL.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 2.04 indicates that 1SHL is not a great score, but indicates only limited risk for bankruptcy at the moment.
1SHL has a Altman-Z score (2.04) which is in line with its industry peers.
1SHL has a debt to FCF ratio of 11.54. This is a negative value and a sign of low solvency as 1SHL would need 11.54 years to pay back of all of its debts.
1SHL has a Debt to FCF ratio (11.54) which is in line with its industry peers.
A Debt/Equity ratio of 0.79 indicates that 1SHL is somewhat dependend on debt financing.
1SHL's Debt to Equity ratio of 0.79 is on the low side compared to the rest of the industry. 1SHL is outperformed by 72.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF 11.54
Altman-Z 2.04
ROIC/WACC1.04
WACC5.62%
1SHL.MI Yearly LT Debt VS Equity VS FCF1SHL.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.3 Liquidity

A Current Ratio of 1.27 indicates that 1SHL should not have too much problems paying its short term obligations.
With a Current ratio value of 1.27, 1SHL is not doing good in the industry: 69.09% of the companies in the same industry are doing better.
A Quick Ratio of 0.85 indicates that 1SHL may have some problems paying its short term obligations.
1SHL has a Quick ratio of 0.85. This is in the lower half of the industry: 1SHL underperforms 65.45% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 0.85
1SHL.MI Yearly Current Assets VS Current Liabilites1SHL.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 2.88% over the past year.
The Earnings Per Share has been growing slightly by 1.21% on average over the past years.
1SHL shows a small growth in Revenue. In the last year, the Revenue has grown by 2.16%.
The Revenue has been growing by 10.05% on average over the past years. This is quite good.
EPS 1Y (TTM)2.88%
EPS 3Y12.81%
EPS 5Y1.21%
EPS Q2Q%-1.89%
Revenue 1Y (TTM)2.16%
Revenue growth 3Y14.45%
Revenue growth 5Y10.05%
Sales Q2Q%4.27%

3.2 Future

The Earnings Per Share is expected to grow by 13.47% on average over the next years. This is quite good.
1SHL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.55% yearly.
EPS Next Y10.05%
EPS Next 2Y13.85%
EPS Next 3Y13.6%
EPS Next 5Y13.47%
Revenue Next Year4.16%
Revenue Next 2Y5.36%
Revenue Next 3Y5.74%
Revenue Next 5Y6.55%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1SHL.MI Yearly Revenue VS Estimates1SHL.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B 25B
1SHL.MI Yearly EPS VS Estimates1SHL.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 25.27, which means the current valuation is very expensive for 1SHL.
1SHL's Price/Earnings ratio is a bit cheaper when compared to the industry. 1SHL is cheaper than 70.91% of the companies in the same industry.
When comparing the Price/Earnings ratio of 1SHL to the average of the S&P500 Index (29.35), we can say 1SHL is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 20.76, the valuation of 1SHL can be described as rather expensive.
Based on the Price/Forward Earnings ratio, 1SHL is valued a bit cheaper than 67.27% of the companies in the same industry.
1SHL is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 25.27
Fwd PE 20.76
1SHL.MI Price Earnings VS Forward Price Earnings1SHL.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

1SHL's Enterprise Value to EBITDA is on the same level as the industry average.
67.27% of the companies in the same industry are more expensive than 1SHL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 41.4
EV/EBITDA 18.5
1SHL.MI Per share data1SHL.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as 1SHL's earnings are expected to grow with 13.60% in the coming years.
PEG (NY)2.51
PEG (5Y)20.95
EPS Next 2Y13.85%
EPS Next 3Y13.6%

3

5. Dividend

5.1 Amount

1SHL has a Yearly Dividend Yield of 1.85%.
Compared to an average industry Dividend Yield of 2.13, 1SHL pays a bit more dividend than its industry peers.
1SHL's Dividend Yield is slightly below the S&P500 average, which is at 2.33.
Industry RankSector Rank
Dividend Yield 1.85%

5.2 History

The dividend of 1SHL decreases each year by -1.10%.
Dividend Growth(5Y)-1.1%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

57.06% of the earnings are spent on dividend by 1SHL. This is a bit on the high side, but may be sustainable.
DP57.06%
EPS Next 2Y13.85%
EPS Next 3Y13.6%
1SHL.MI Yearly Income VS Free CF VS Dividend1SHL.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B
1SHL.MI Dividend Payout.1SHL.MI Dividend Payout, showing the Payout Ratio.1SHL.MI Dividend Payout.PayoutRetained Earnings

SIEMENS HEALTHINEERS AG

BIT:1SHL (3/3/2025, 7:00:00 PM)

54.08

+5.29 (+10.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-31 2024-07-31/bmo
Earnings (Next)11-06 2024-11-06/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap60.49B
Analysts81.48
Price Target59.62 (10.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.85%
Yearly Dividend0.95
Dividend Growth(5Y)-1.1%
DP57.06%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.46%
Min EPS beat(2)-0.13%
Max EPS beat(2)5.04%
EPS beat(4)2
Avg EPS beat(4)0.68%
Min EPS beat(4)-11.52%
Max EPS beat(4)9.31%
EPS beat(8)5
Avg EPS beat(8)2.59%
EPS beat(12)7
Avg EPS beat(12)1.88%
EPS beat(16)9
Avg EPS beat(16)28.7%
Revenue beat(2)0
Avg Revenue beat(2)-2.24%
Min Revenue beat(2)-3.02%
Max Revenue beat(2)-1.45%
Revenue beat(4)1
Avg Revenue beat(4)-0.8%
Min Revenue beat(4)-3.02%
Max Revenue beat(4)2.35%
Revenue beat(8)2
Avg Revenue beat(8)-0.67%
Revenue beat(12)6
Avg Revenue beat(12)0.17%
Revenue beat(16)8
Avg Revenue beat(16)0.78%
PT rev (1m)-1.03%
PT rev (3m)-1.03%
EPS NQ rev (1m)-3.96%
EPS NQ rev (3m)-3.96%
EPS NY rev (1m)0.13%
EPS NY rev (3m)0.13%
Revenue NQ rev (1m)-2.52%
Revenue NQ rev (3m)-2.52%
Revenue NY rev (1m)-1.34%
Revenue NY rev (3m)-1.34%
Valuation
Industry RankSector Rank
PE 25.27
Fwd PE 20.76
P/S 2.74
P/FCF 41.4
P/OCF 27.69
P/B 3.32
P/tB N/A
EV/EBITDA 18.5
EPS(TTM)2.14
EY3.96%
EPS(NY)2.61
Fwd EY4.82%
FCF(TTM)1.31
FCFY2.42%
OCF(TTM)1.95
OCFY3.61%
SpS19.75
BVpS16.3
TBVpS-6.39
PEG (NY)2.51
PEG (5Y)20.95
Profitability
Industry RankSector Rank
ROA 4%
ROE 10.22%
ROCE 7.68%
ROIC 5.85%
ROICexc 6.26%
ROICexgc 26.67%
OM 12.32%
PM (TTM) 8.43%
GM 37.82%
FCFM 6.61%
ROA(3y)3.83%
ROA(5y)4.89%
ROE(3y)9.79%
ROE(5y)11.34%
ROIC(3y)5.68%
ROIC(5y)7.29%
ROICexc(3y)5.97%
ROICexc(5y)7.68%
ROICexgc(3y)32.99%
ROICexgc(5y)32.15%
ROCE(3y)7.45%
ROCE(5y)9.56%
ROICexcg growth 3Y6.13%
ROICexcg growth 5Y-3.99%
ROICexc growth 3Y-15.97%
ROICexc growth 5Y-13.46%
OM growth 3Y-9.96%
OM growth 5Y-7.42%
PM growth 3Y-10.65%
PM growth 5Y-5.87%
GM growth 3Y-2.69%
GM growth 5Y-2.67%
F-Score7
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF 11.54
Debt/EBITDA 3.64
Cap/Depr 58.34%
Cap/Sales 3.28%
Interest Coverage 10.19
Cash Conversion 55.14%
Profit Quality 78.42%
Current Ratio 1.27
Quick Ratio 0.85
Altman-Z 2.04
F-Score7
WACC5.62%
ROIC/WACC1.04
Cap/Depr(3y)60.71%
Cap/Depr(5y)68.77%
Cap/Sales(3y)3.84%
Cap/Sales(5y)3.87%
Profit Quality(3y)98.94%
Profit Quality(5y)92.03%
High Growth Momentum
Growth
EPS 1Y (TTM)2.88%
EPS 3Y12.81%
EPS 5Y1.21%
EPS Q2Q%-1.89%
EPS Next Y10.05%
EPS Next 2Y13.85%
EPS Next 3Y13.6%
EPS Next 5Y13.47%
Revenue 1Y (TTM)2.16%
Revenue growth 3Y14.45%
Revenue growth 5Y10.05%
Sales Q2Q%4.27%
Revenue Next Year4.16%
Revenue Next 2Y5.36%
Revenue Next 3Y5.74%
Revenue Next 5Y6.55%
EBIT growth 1Y26.43%
EBIT growth 3Y3.05%
EBIT growth 5Y1.88%
EBIT Next Year60.06%
EBIT Next 3Y27.1%
EBIT Next 5Y19.53%
FCF growth 1Y-7.47%
FCF growth 3Y-2.24%
FCF growth 5Y3.76%
OCF growth 1Y-7.81%
OCF growth 3Y3.2%
OCF growth 5Y5.85%